Drug interactions
Eslicarbazepine + Vincristine liposomal
Severity: Minor
Eslicarbazepine and Vincristine liposomal: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Vincristine is a CYP3A4 substrate, and enzyme-inducing antiseizure drugs can lower its exposure and efficacy. Eslicarbazepine is a weaker inducer, so the effect is expected to be modest.
What this interaction means in plain words
Eslicarbazepine and Vincristine liposomal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Weak CYP3A4 induction by eslicarbazepine may increase vincristine clearance.
What to do
No empirical dose change is needed. Monitor oncologic response and neurotoxicity, and prefer a non-inducing antiseizure drug if suppressed efficacy is a concern.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Eslicarbazepine and Vincristine liposomal, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Eslicarbazepine
- Eslicarbazepine + Mavacamten Contraindicated
- Eslicarbazepine + Rilpivirine Contraindicated
- Artemether / lumefantrine + Eslicarbazepine Major
- Avapritinib + Eslicarbazepine Major
- Bedaquiline + Eslicarbazepine Major
- Benzhydrocodone / acetaminophen + Eslicarbazepine Major
Frequently asked questions
Can I take Eslicarbazepine with Vincristine liposomal?
MediHelp rates the interaction as minor. Eslicarbazepine and Vincristine liposomal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Vincristine is a CYP3A4 substrate, and enzyme-inducing antiseizure drugs can lower its exposure and efficacy. Eslicarbazepine is a weaker inducer, so the effect is expected to be modest.
How serious is the interaction between Eslicarbazepine and Vincristine liposomal?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose change is needed. Monitor oncologic response and neurotoxicity, and prefer a non-inducing antiseizure drug if suppressed efficacy is a concern.
What other medicines interact with Eslicarbazepine?
MediHelp also lists interactions of Eslicarbazepine with, for example, Mavacamten, Rilpivirine, Artemether / lumefantrine. The full list is on the Eslicarbazepine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
